NCT02658266

Brief Summary

Adults with complex congenital heart disease have impaired muscle function compared both to health controls and patients with lesions classified as simple. There is only one study assessing the effects of resistance training in patients palliated with Fontan procedure. The hypotheses of the present study is that home based resistance training will improve muscle function in adults with different complex congenital hear diseases.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2016

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 11, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 18, 2016

Completed
14 days until next milestone

Study Start

First participant enrolled

February 1, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2019

Completed
Last Updated

September 14, 2017

Status Verified

August 1, 2016

Enrollment Period

2 years

First QC Date

January 11, 2016

Last Update Submit

September 13, 2017

Conditions

Keywords

resistance trainingadultmuscle strengthmuscle endurancemuscle metabolism

Outcome Measures

Primary Outcomes (1)

  • Change in muscle strength (Newton, N)

    Change from baseline muscle strength at 12 weeks follow-up

Secondary Outcomes (6)

  • Change in muscle endurance (number of repetitions)

    Change from baseline muscle endurance at 12 weeks follow-up

  • Change in total body skeletal muscle mass (kg)

    Change from baseline total body skeletal muscle mass at 12 weeks follow-up

  • Change in appendicular skeletal muscle mass (kg)

    Change from baseline appendicular skeletal muscle mass at 12 weeks follow-up

  • Change in body fat percentage

    Change from baseline body fat percentage at 12 weeks follow-up

  • Change in bone mineral density (g/cm2)

    Change from baseline bone mineral density at 12 weeks follow-up

  • +1 more secondary outcomes

Other Outcomes (2)

  • Compliance to study protocol

    At completion of study protocol 12 weeks

  • Adverse events

    Once a week from the date of onset of the home based exercise regimen until the followup at 12 weeks

Study Arms (2)

Resistance training

EXPERIMENTAL

Home based resistance training 12 weeks home based resistance training 3 times per week, 10-12 reps, 2 sets

Behavioral: Home based resistance training

Control group

NO INTERVENTION

No instructed exercise training. Continue with habitual physical activity.

Interventions

The participants in the intervention group will receive an individualized resistance training program. The individual adjustments in load will will be made from the results of the muscle function and muscle strength tests. The resistance training will be home based and performed 3 times per week 10-12 reps 2 sets 12 weeks. Increment of load will be performed continuously according to rating of perceived exertion.

Resistance training

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Complex congenital heart disease ( e.g. tetralogy of Fallot, transposition of the great arteries, pulmonary atresia, patients palliated with Fontan procedure or total cavo-pulmonary connection).
  • Clinically stable without significant change the last 3 months.
  • Adult (\> 18 years of age).
  • Informed consent.

You may not qualify if:

  • Cognitive impairment affecting the ability of independent decision making.
  • Present strategy of regularly executing resistance training \> 2times per week in purpose to increase muscle strength.
  • Other comorbidity affecting physical activity.
  • Other circumstance making participation unsuitable.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Skåne University hospital

Lund, 22185, Sweden

COMPLETED

University Hospital

Umeå, 90185, Sweden

RECRUITING

University Hospital Uppsala

Uppsala, Sweden

RECRUITING

Related Publications (5)

  • Sandberg C, Thilen U, Wadell K, Johansson B. Adults with complex congenital heart disease have impaired skeletal muscle function and reduced confidence in performing exercise training. Eur J Prev Cardiol. 2015 Dec;22(12):1523-30. doi: 10.1177/2047487314543076. Epub 2014 Jul 18.

    PMID: 25038081BACKGROUND
  • Cordina R, O'Meagher S, Gould H, Rae C, Kemp G, Pasco JA, Celermajer DS, Singh N. Skeletal muscle abnormalities and exercise capacity in adults with a Fontan circulation. Heart. 2013 Oct;99(20):1530-4. doi: 10.1136/heartjnl-2013-304249. Epub 2013 Jul 11.

    PMID: 23846614BACKGROUND
  • Kroonstrom LA, Johansson L, Zetterstrom AK, Dellborg M, Eriksson P, Cider A. Muscle function in adults with congenital heart disease. Int J Cardiol. 2014 Jan 1;170(3):358-63. doi: 10.1016/j.ijcard.2013.11.014. Epub 2013 Nov 13.

    PMID: 24295897BACKGROUND
  • Sandberg C, Rinnstrom D, Dellborg M, Thilen U, Sorensson P, Nielsen NE, Christersson C, Wadell K, Johansson B. Height, weight and body mass index in adults with congenital heart disease. Int J Cardiol. 2015;187:219-26. doi: 10.1016/j.ijcard.2015.03.153. Epub 2015 Mar 18.

    PMID: 25838217BACKGROUND
  • Williams CA, Wadey C, Pieles G, Stuart G, Taylor RS, Long L. Physical activity interventions for people with congenital heart disease. Cochrane Database Syst Rev. 2020 Oct 28;10(10):CD013400. doi: 10.1002/14651858.CD013400.pub2.

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Bengt Johansson, MD, Phd

    Umea University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bengt Johansson, MD, PhD

CONTACT

Camilla Sandberg, PhD stud

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2016

First Posted

January 18, 2016

Study Start

February 1, 2016

Primary Completion

February 1, 2018

Study Completion

February 1, 2019

Last Updated

September 14, 2017

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share

Locations